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Objective: Analysis of outcomes after coronary artery bypass grafting has 
focused on risk factors for operative mortality. Nonfatal perioperative 
morbidity is far more costly and more common after operation. To identify 
the risk factors that lead to postoperative morbidity, we evaluated 938 
patients undergoing coronary artery bypass grafting at Albany Medical 
Center Hospital during 1993. Methods: Multivariate statistical analysis was 
performed on preoperative patient variables to identify risk factors for 
either serious postoperative morbidity or increased hospital ength of stay. 
Variables were considered both individually and in combination. For 
example, age was considered individually or in combination with other 
variables, including parameters of blood volume (i.e., age divided by red 
blood cell volume or Age/RBCVOL). Similar multivariate analysis was 
performed to identify independent risk factors for hospital mortality. 
Results: In order of decreasing importance, the following patient variables 
were significantly associated with increased length of stay by stepwise Cox 
regression analysis: Age/RBCVOL, history of congestive heart failure, 
hypertension, femoral-popliteal peripheral vascular disease, chronic ob- 
structive lung disease, and renal dysfunction. The combination variable, 
Age/RBCVOL, was an important risk factor for both increased length of 
stay and serious postoperative morbidity. Variables that were significant 
independent predictors of increased mortality, such as preoperative shock, 
and redo operation, were not risk factors for either serious morbidity or 
increased length of stay. Conclusions: We conclude that risk factors for 
postoperative morbidity are different from those for postoperative mortal- 
ity. These results uggest that older patients with preoperative anemia nd low 
blood volume who also have other comorbidities (congestive heart failure, 
stroke, chronic obstructive pulmonary disease, or hypertension) are at in- 
creased risk for postoperative complications. This allows identification of a 
high-risk cohort of patients who are likely candidates for interventions to 
lessen postoperative morbidity. (J THORAC CARDIOVASC SURG 1996;111:731-41) 
A nalysis of outcomes after cardiac operations, especially coronary artery bypass grafting 
(CABG), has assumed new importance because of 
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concerns about the cost of surgical interventions. 
Arguably, the most modifiable component of hospi- 
tal cost in patients undergoing cardiac procedures i
nonfatal perioperative morbidity. Before surgeons 
or health care organizations can make rational 
decisions regarding patients in whom risk is high, 
they must know what factors predispose patients to 
costly morbidity and increased hospital length of 
stay (LOS) after operation. 
An analysis at our institution revealed that signif- 
icant components of hospital cost in patients under- 
going CABG were prolonged hospital LOS and 
serious postoperative morbidity. As much as 40% of 
the total cost of CABG during i year was accounted 
for by patients having serious postoperative morbid- 
ity with resultant prolonged hospital LOS. The first 
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step in lowering costs associated with CABG was to 
identify risk factors that predispose patients to seri- 
ous postoperative morbidity and increased LOS. 
Only after knowing what the risk factors are that 
predispose to increased morbidity can strategies be 
devised to limit morbidity and ultimately lower 
costs. 
Numerous reports have catalogued the preopera- 
tive risk factors predictive of operative mortality, 1-4 
and some others have identified risk factors for 
postoperative morbidity or hospital LOS. TM Be- 
cause of the need to better define factors that 
influence post-CABG morbidity and to implement 
strategies that limit costs of operation, we under- 
took a study to identify risk factors for serious 
hospital morbidity and increased LOS. We used the 
cohort of patients undergoing CABG at Albany 
Medical Center Hospital during 1993 as a study 
population to perform this risk analysis. 
Methods and patient selection 
Patient database. All patients undergoing CABG at 
Albany Medical Center in 1993 were evaluated. Only 
patients who were operated on and discharged in 1993 
were entered into the study group. With these criteria, 938 
patients were studied and records were available for each 
of the study patients. A few patient records were incom- 
plete, but more than 98% of all data elements for each 
patient record were available for analysis. Two databases 
were combined to form the final database from which the 
numerical calculations were performed: (1) the New York 
State cardiac surgery database for Albany Medical Center 
and (2) the Albany Medical Center perfusion database. 
Combining these two databases provided a double check 
to ensure that no patients were inadvertently omitted 
from either database. Only patients having initial or 
reoperative CABG were included in the study group. 
Patients having CABG in conjunction with other proce- 
dures such as valve replacement or repair of a mechanical 
defect after myocardial infarction were excluded. 
Risk factors. Preoperative variables that might be as- 
sociated with increased LOS or morbidity were evaluated 
by multivariate statistical methods. A complete list of all 
the preoperative variables examined and their definitions 
are shown in Appendix 1. Variables were considered both 
individually and in combination if there was evidence that 
variable interaction existed. For example, patient age was 
considered individually or in combination with blood 
volume, renal function, cardiac function, and hematocrit 
value. For the multivariate analyses, composite variables 
were used in place of individual variables, whenever 
feasible, to minimize variable interactions and to improve 
the validity of the resultant multivariate models. An 
attempt was made to reduce this redundancy and variable 
interaction to a minimum. 12 In particular, two composite 
variables were used that greatly improved both the mul- 
tivariate logistic regression and the Cox proportional 
hazards model. These two composite variables were Age/ 
RBCVOL and PROBMORT. Age/RBCVOL is the ratio 
of age divided by the packed red blood cell volume 
(RBCVOL). The RBCVOL is defined as the patient's 
blood volume (calculated from height, weight, and gen- 
der) multiplied by the preoperative hematocrit value. The 
RBCVOL was approximated by means of a nomogram. 
No attempt was made to determine the true blood volume 
by quantitative methods. Similarly, PROBMORT is a 
composite variable that combines multiple patient risk 
factors into a single risk-adjusted probability of in-hospital 
mortality (see Appendix 2). The validity of PROBMORT 
has been confirmed by the use of large data series from 
patients undergoing CABG in New York State. 2 This 
composite variable has been a reliable indicator of mor- 
tality risk in this population. 
Outcome variables. Three outcome variables were 
measured: (1) hospital LOS, (2) serious postoperative 
morbidity, and (3) hospital mortality. Serious postopera- 
tive morbidity was defined as the occurrence of any of the 
following during the postoperative course: postoperative 
myocardial infarction (Q wave), stroke, pulmonary failure 
(more than 5 days on the ventilator), renal failure neces- 
sitating dialysis, postoperative cardiogenic shock necessi- 
tating left ventricular assist device or intraaortic balloon 
pump, sepsis, or mediastinitis. LOS was measured from 
the day of operation to the day of discharge or death. 
Hospital mortality was defined as any death during the 
postoperative stay, regardless of whether the cause of 
death was directly related to the operation or only re- 
motely related. 
Statistical modeling--multivariate testing. Only pre- 
operative variables were included in the multivariate 
analyses as independent or predictor variables. Intraoper- 
ative or postoperative variables such as isehemic time, 
chest ube drainage, amount of blood products consumed, 
or number of CABGs were not entered into the multiva- 
riate models, because it would be difficult to estimate the 
value of these variables before the operation for the 
purpose of a predictive model. 
For operative mortality, logistic regression analysis with 
stepwise addition of variables was used to determine 
independent predictors of operative death. A contingent 
probability of 0.10 or less was used to enter variables into 
the logistic model in a forward-stepping manner, and a 
contingent probability of 0.15 or less was used to remove 
variables from the model. 
Similarly, Stepwise logistic regression was used to eval- 
uate serious postoperative morbidity using similar entry 
and removal criteria. Serious postoperative morbidity was 
considered a dichotomous variable with discrete values of 
zero if patients had an uncomplicated hospital course or 
one if the patient had one or more serious postoperative 
complications. Independent predictor variables that con- 
tributed to the final multivariate logistic regression model 
were screened for variable interactions and were excluded 
or combined if significant colinearity was found. 12 Inde- 
Pendent predictor variables that contributed to the final 
multivariate model were considered significant risk factors 
for serious postoperative morbidity if the p value for 
improvement in )(2 was 0.05 or less. 
Cox proportional hazards regression with stepwise ad- 
dition of variables was used to determine independent 
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Table I. Logistic regression model for significant multivariate predictors of operative mortality 
Observed percent 
Risk factor mortality (95% CI) Odds ratio (95% CI) X e improvement 
None* (348 patients) 
PROBMORT (683 patients with value 
-< mean of 0.025) 
Dialysis-dependent renal failure (7 patients) 
CHF (91 patients) 
LVH (78 patients) 
Femoral-popliteai peripheral vascular 
disease (74 patients) 
0.3% (0.6%) 0.07 (0.009-0.53) - -  
0.9% for patients with 8.0 (3.3-19.5) 21.279 
<- mean value (0.2%-1.6%) 
28.6% (0%-73.6%) 13.2 (1.3-132) 6.938 
12.1% (5.3%-18.9%) 8.8 (3.8-20.3) 11.097 
7.7% (1.7%-13.7%) 3.9 (1.5-10.1) 5.111 
8.1% (1.7%-14.5%) 4.1 (1.6-10.8) 4.131 
C/, Confidence interval; CH1~; congestive heart failure; PROBMORT, risk-adjusted probability of in-hospital death as determined by New York State risk 
model for CABG mortality; LV/-L, left ventricular hypertrophy. 
*For purposes of calculating zero risk factor scores, PROBMORT was assumed to be -<0.01 (one standard eviation below the mean). 
predictors of hospital LOS, because this outcome is a 
time-dependent continuous variable. 13' 14 Perioperative 
deaths were included in the Cox analysis, and the time 
from operation to discharge or death was considered the 
survival time for analysis of survival time data in the Cox 
proportional-hazards regression model. A probability of 
0.10 or less was used to enter variables into the Cox model in 
a forward-stepping manner, and a probability of 0.15 or less 
was used to remove variables from the model. Independent 
predictor variables that contributed to the final multivariate 
model were considered significant risk factors for LOS if the 
p value for improvement in 9~ was 0.05 or less. 
Statistical calculations were carried out with BMDP 
statistical software (BMDP Software, Los Angeles, Calif.) 
programs on a personal computer. The adequacy of the 
final multivariate regression models (either logistic regres- 
sion or Cox analysis) was judged by means of various 
regression diagnostics. For logistic regression, receiver 
operating curves were used to assess model performance. 
For Cox regression analysis, the final model derived from 
1993 data at Albany Medical Center Hospital was used to 
develop multivariate risk factors and a risk scoring system 
(described later). The risk scoring system was cross- 
validated with 1994 data from the same institution to 
assess the predictive ability of the Cox model and the risk 
scoring system. 
A risk score for hospital LOS was determined for each 
patient by adding the weighted score for each significant 
risk factor in the final Cox model. The weights were 
obtained from the coefficients for each prognostic factor 
in the final model. 5' 11 Since the baseline survivor function 
is altered by the risk scores in an incremental way with 
increasing risk scores causing rightward shift of the base- 
line decay curve (i.e., shift toward increased LOS), it is 
possible to calculate a predicted LOS from a patient's 
preoperative risk score. For purposes of cross-validation, 
the predicted 50th percentile LOS was calculated by 
inverting the hazard function by means of the following 
equation: 
50th Percentile LOS = 1/Hazard function 
_ 0.5exp(riskscore/10) 
The predicted LOS in days was computed for patients 
operated on in 1994 at Albany Medical Center Hospital 
from this equation. To relate LOS to the risk score, one 
must calculate incremental values of LOS from the base- 
line Cox regression decay curve multiplied by conversion 
factors for each different risk score. These predicted 
values for LOS were compared with the observed values 
for each patient over the entire range of risk scores. By 
using the 1993 data as a "training" set and the 1994 data 
as the "cross-validation" set, we assessed the validity of 
the Cox model and the risk scoring system. 
Results 
Postoperative mortality. Among the 938 patients 
undergoing initial or reoperative CABG during 
1993 at Albany Medical Center Hospital, there were 
24 operative deaths (2.6%). The significant multi- 
variate predictors of increased mortality by logistic 
regression are shown in Table I. The most important 
risk factor for operative mortality was the composite 
variable PROBMORT.  This variable represents a
compilation of variables found to be significantly 
associated with fatal outcome in the New York State 
cardiac surgery database (Appendix 2). The impor- 
tant components of PROBMORT include preoper- 
ative shock, left ventricular dysfunction, reoperative 
surgery, and preoperative renal failure. 2 
Serious postoperative morbidity. Eighty patients 
(8.5%) had a serious postoperative complication. 
The type and number of serious complications ex- 
perienced after CABG are shown in Table II. Forty 
patients had a single serious complication, whereas 
40 more had a combination of complications. Be- 
cause the number of patients having two (23 pa- 
tients), three (9 patients), four (7 patients), or five (1 
patient) complications was relatively small, serious 
postoperative morbidity was considered a dichoto- 
mous (yes or no) variable. 
Logistic regression analysis revealed four vari- 
ables to be significantly associated with any serious 
postoperative morbidity. The relative magnitude of 
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Fig. 1. Hospital LOS for patients with serious morbidity or 
mortality. Error bars represent s andard error of the mean. 
Table II. Type and number of serious postoperative 
complications 
Patients with 
additional 
complications 
associated with 
morbidity or mortality Total patients 
Morbidity or with morbidity 
mortality 0 1 2 3 4 or mortality 
Death 9 10 2 3 0 24 
Stroke 9 4 2 0 0 15 
MI 2 0 1 0 0 3 
IABP 9 3 1 0 0 13 
Pulmonary failure 8 6 3 3 1 21 
Renal failure 3 0 0 1 0 4 
Total 40 23 9 7 1 80 
MI, Q-wave perioperative myocardial infarction; IABP, intraaortic balloon 
counterpulsation required for weaning from cardiopulmonary bypass. 
Table III. Logistic regression model for significant multivariate predictors of serious postoperative morbidity 
Risk factor Observed complication rate Odds ratio X 2 
(patients with r&k factor) (95% CI) (95% CI) improvement 
None (51 patients)* 
CHF (91 patients) 
Age/RBCVOL (385 patients with 
mean value -> 0.0390) 
Hypertension (646 patients) 
Previous troke (51 patients) 
0.02% (0%-26.1%) 0.2 (0.03-1.5) - -  
22.0% (13.4%-30.6%) 3.1 (1.8-5.6) 25.857 
18.4% (12.4%-24.4%) 13.7 (6.7-27.7) 11.931 
10.2% (7.9%-12.5%) 2.3 (1.2-4.1) 8.795 
19.6% (8.3%-30.9%) 2.8 (1.4-5.9) 4.686 
C/, Confidence interval; CHF, congestive heart failure during admission and requiring CABG; Age/RBCVOL, age in years divided by red blood cell volume 
obtained from nomogram of patient height, weight, gender, and preoperative hematocrit value. 
*For purposes of calculating zero risk factor scores, Age/RBCVOL was assumed to be <0.025 (one standard eviation below the mean). 
the effect of these risk factors on postoperative 
morbidity is shown in Table III. The combination 
variable Age/RBCVOL represents a semiquantita- 
tive measure of the preoperative anemia and body 
size and was an important risk factor associated with 
serious morbidity. The variables associated with 
serious morbidity shown in Table III are different 
from those associated with operative mortality 
shown in Table I. 
Postoperat ive  LOS. The mean LOS for patients 
undergoing CABG was 8.4 days (95% confidence 
interval = 0.45 days). The LOS was significantly 
longer in patients who had serious morbidity or who 
died than in those who had an uncomplicated pro- 
cedure (Fig. 1). 
Hospital LOS was considered to be a time-depen- 
dent, continuous variable and, as such, was evalu- 
ated by means of survival analysis techniques. Pre- 
dictor variables that were significant independent 
predictors of the LOS are shown in Table IV. The 
most important risk factor for increased LOS was 
Age/RBCVOL. This suggests that risks for a global 
index of morbidity and resource use (i.e., LOS) are 
different from those for mortality. 
By considering the Cox regression coefficients, it
is possible to develop a set of weighted risk scores 
for each of the significant variables that contribute 
to the Cox regression. Table IV shows the odds 
ratios and the Cox regression coefficients obtained 
from the multivariate analysis. 5'14 For computa- 
tional purposes the regression coefficients were con- 
verted to "risk scores" by rounding off the regres- 
sion coefficient values to the nearest integer. For 
example, the risk score for having preoperative r nal 
dysfunction is 6 (rounded up from 5.64). In the case 
of the predictor variable Age/RBCVOL, the risk 
score is computed by multiplying the actual value of 
the variable by 181.3. As an example, a patient who 
is 75 years old and has a preoperative RBCVOL of 
1800 ml would have a value of Age/RBCVOL of 
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Table IV. Cox proportional hazards regression model for significant predictor variables associated 
with hospital LOS 
Odds ratio for mean 
Risk factor (patients LOS >- 8.4 days Cox regression X 2 
with risk factor) Observed LOS (95% CI) (95% CI) coefficient improvement 
None (40 patients)* 5.9 days (5.2-6.6 days) 0.14 (-1.9-0.6) 1.00 - -  
Age/RBCVOL (385 patients with 10.0 days (9.0-11.0 days) 2.6 (1.9-3.4) 1.813 per 0.010 unit 72.907 
> mean value of 0.0390) of Age/RBCVOL 
CHF (91 patients) 11.6 days (9.3-13.9 days) 2.6 (1.7-4.1) 4.534 17.729 
Hypertension (646 patients) 9.0 days (8.4-9.6 days) 2.1 (1.5-2.9) 2.312 12.296 
Femoral-popliteal vascular disease 10.1 days (8.7-11.5 days) 2.7 (1.6-4.3) 3.0159 8.053 
(74 patients) 
Renal dysfunction (17 patients)t 12.8 days (9.0-16.6 days) 5.4 (2.0-14.9) 5.64 6.904 
COPD (213 patients) 9.4 days (8.5-10.3 days) 1.9 (1.3-2.6) 2.23 7.259 
Previous stroke (51 patients) 11.1 days (8.9-13.3 days) 3.5 (2.0-6.2) 3.20 5.017 
LOS, Length of stay; C/, confidence interval; Age/RBCVOL, age in years divided by red blood cell volume obtained from nomogram of patient height, weight, 
gender, and preoperative hematocrit value; CHF, congestive heart failure immediately preceding CABG; COPD, chronic obstructive pulmonary disease. 
*For purposes of calculating zero risk factor scores, Age/RBCVOL was assumed to be <0.0250 (one standard eviation below the mean). 
tSerum creatinine concentration >-2.5 mg/dl but not dialysis-dependent. 
0.042. The computed risk score for this patient for 
Age/RBCVOL would be 7.6, or 8 rounded to the 
nearest integer. The computed risk scores are re- 
lated to the baseline decay curve for LOS in an 
incremental way, as shown in Fig. 2. This means that 
as one or more significant variables contribute to the 
decay curve function, the curve is shifted to the right 
(i.e., toward longer hospital stay). The mathematical 
relationship between risk score and LOS is shown in 
Fig. 3 for the 10th, 50th, and 90th percentiles of 
LOS. A patient's preoperative risk score can be 
calculated by adding the individual weighted scores 
that apply. For a given risk score, it is possible to 
estimate a 50th percentile value (or any other 
percentile) for LOS, and a graphic display of the 
50th percentile of LOS is shown in Fig. 3. 
Regression diagnostics. For the logistic regres- 
sions, it is possible to use model diagnostics toassess 
the quality of the regression model. For the two 
logistic regression models generated, the diagnostics 
suggest that the values of outcome (either serious 
morbidity or mortality) predicted by the regression 
equations fit the observed values well. For example, 
the area under the receiver operating characteristic 
curve for model prediction of operative mortality is 
0.8004. For serious perioperative morbidity, the 
area under the receiver operating characteristic 
curve is 0.710. 
The adequacy of the Cox regression model in 
predicting hospital LOS was assessed by means of 
cross-validation techniques. For this analysis, the 
1993 results at Albany Medical Center Hospital 
were used to predict he LOS of patients undergoing 
operation during 1994. Fig. 4 compares the observed 
1994 LOS data with the predicted LOS developed 
from the 1993 "training" data set for each level of 
risk score. There is good agreement between pre- 
dicted and observed values in the 1994 cross-valida- 
tion data set, suggesting that the Cox model de- 
scribed in Table IV is a satisfactory epresentation 
of the observed findings. 
Discussion 
These results suggest hat there is a difference 
between the risk factors associated with postopera- 
tive morbidity and those that lead to operative 
mortality. The multivariate r sults hown in Tables 
III and IV point out unique risk factors associated 
with postoperative morbidity (as measured by LOS 
and serious complications) that are not significantly 
related to operative mortality. For example, the 
composite variable PROBMORT is a significant 
predictor variable for postoperative mortality but 
does not contribute to the regression models for 
either LOS or serious morbidity. Likewise, Age/ 
RBCVOL is an important determinant of postoper- 
ative morbidity (as measured by either LOS or 
serious complications) but does not contribute to 
the multivariate regression for mortality. This dif- 
ference between predictors of mortality and morbid- 
ity has clinical implications. Important risk factors 
that predict mortality include measures of ventricu- 
lar function, reoperative surgery, or hemodynamic 
instability (Appendix 2). As opposed to this, multi- 
variate risk factors for morbidity emphasize mea- 
sures of small body stature (as measured by blood 
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Fig. 2. Decay curves (fraction remaining hospitalized) 
for patients with varying risk scores. The values used to 
generate these curves are hypothetical, calculated values 
obtained from the baseline decay curve and from expo- 
nential conversion factors related to the relative risk for 
each significant variable in the Cox regression analysis. 
CHF, Congestive heart failure. 
volume) and chronic illness or anemia. Indexes of 
chronic illness that are multivariate predictors of 
morbidity include anemia nd small body stature (as 
measured by RBCVOL), as well as previous troke, 
renal dysfunction, and hypertension. Although the 
variables overlap somewhat, these results suggest 
that risk factors for morbidity are different from 
those for mortality, with parameters of chronic 
illness being more commonly associated with pro- 
longed hospital stay and serious postoperative com- 
plications. 
Our data not only support the contention that 
LOS is a continuous variable that correlates with 
serious morbidity but also suggest that LOS can be 
used in a prospective manner to study postoperative 
morbidity. The risk scoring system developed from 
the Cox regression model can be used as a measure 
of risk for prolonged LOS and increased morbidity. 
The results of the calculations shown in Figs. 2 and 
4 suggest at least three ways that these risk scores 
might be used in a prospective manner: First, com- 
putation of the risk score for a given patient before 
operation provides an objective estimate of the 
chance of prolonged hospitalization, serious postop- 
erative morbidity, and presumably, increased cost. 
For example, apatient with a preoperative risk score 
of 15 has a greater than 50% chance of staying in the 
hospital more than 14 days (incidentally the limit of 
diagnosis-related group reimbursement for CABG) 
after operation. Physicians can benefit from this 
knowledge, both in the approach to the patient and 
in providing informed consent regarding high-risk 
procedures. Second, patients with the highest risk 
score values are candidates for more costly interven- 
tions that might reduce LOS. Such interventions as 
use of heparin-bonded oxygenator circuits 15' 16 or 
aprotinin therapy to limit blood transfusion 17might 
be viewed as cost-saving measures in patients in 
whom the risk is high, rather than expensive inter- 
ventions that are not justified for routine use in 
patients in whom the risk is average. Any investiga- 
tion into the reduction of morbidity and limitation 
of hospital costs should focus on the patients at 
highest risk, and the risk-scoring system outlined 
here is an ideal way to identify a high-risk study 
population. Third, the risk-scoring system outlined 
here is an ideal way to study changes over time in 
the high-risk study population. Characteristics of the 
high-risk subset as measured by changes in the risk 
score patterns can serve as a gauge of success or 
failure in improving outcome by decreasing morbid- 
ity and LOS. 
Using the above-described risk scores to identify a 
high-risk subset of patients who are likely candidates 
for interventions to limit morbidity is exactly analo- 
gous to application of "total quality management" 
principles to an industrial process or to any other 
complex process. For example, only 8% of the 
patients having CABG stay longer that 14 days after 
operation, but this minority account for more than 
25 % of the total hospital cost of patients undergoing 
CABG. A logical starting point for efforts to de- 
crease costs of CABG should be to focus on this 
high-risk subset of patients who consume a dispro- 
portionate amount of resources. The observation 
that a few factors account for the majority of the 
outcomes of a complex process has been termed the 
pareto principle in the jargon of total quality man- 
agement and has proved to be a valuable tool in 
improving quality, is The risk-scoring system out- 
lined herein could serve both as a starting point to 
identify patients at high risk and as a means of 
monitoring success or failure in influencing outcome 
in this high-risk subset. An analogous approach as 
been used in the National Demonstration Project on 
Quality Improvement in Health Care. 19 
It is noteworthy that the composite variable, 
Age/RBCVOL, is a significant independent predic- 
tor of both serious morbidity and LOS. Age/ 
RBCVOL is a semiquantitative measure of body 
size and anemia. The RBCVOL is not calculated 
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Fig. 4. Comparisons of predicted LOS from 1993 data to actual LOS from 1994 data. Error bars represent 
standard error of the mean for 1993 data. 
from exact blood volume measurements but from 
estimates of blood volume. Despite the approxima- 
tions used in estimating this variable, the results are 
both reproducible and important predictors of 
increased morbidity. We 2°'21 have found that 
RBCVOL is also an independent variable signifi- 
cantly associated with excessive postoperative blood 
transfusion. It is more than just coincidental that 
excessive blood transfusion is significantly associ- 
ated with increased postoperative morbidity. Our 
study does not identify whether excessive blood 
transfusion is a cause or effect of increased LOS, but 
there is no doubt that the two variables are related. 
It is tempting to speculate that limitation of postop- 
erative blood product use will result in decreased 
LOS and morbidity. Further studies are required to 
test this hypothesis. 
There are some limitations of the studies pre- 
sented. Even though the regression diagnostics sug- 
gest that the methods used to describe serious 
morbidity and mortality are appropriate and yield 
good results, it remains for the regression models 
presented to be tested in larger groups of patients 
and at multiple institutions. Because all of these 
results were obtained at one institution, it is not 
clear how generally applicable they will be to other 
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smaller or larger facilities. Likewise, these results 
encompass only CABG operations,  and the applica- 
bil ity of the regression analysis to other types of 
cardiac operat ions is uncertain. A more serious 
shortcoming involves selection bias. Only surgical 
patients were included in the study. An  important  
unstudied feature of the populat ion with coronary 
disease is the morbidity risks associated with non- 
operat ive therapy. Pro longed hospital izat ion and 
increased cost may be greater with nonoperat ive 
therapy than with operat ive therapy in patients at 
high risk. Our  results do not address this issue and 
further studies are required to unravel the morbidity 
risks of operat ive versus nonoperat ive therapy of 
coronary artery disease. 
In summary, we have shown that preoperat ive 
variables that predict  operat ive mortal i ty are differ- 
ent from those that predict  serious morbidity or 
increased LOS. A part icularly sensitive indicator of 
morbidity is the composite variable, Age/RBCVOL.  
This variable and others that reflect chronic health 
status and older age seem to be more predict ive of 
increased morbidity, whereas parameters  of myocar- 
dial dysfunction are predict ive of mortality. Under -  
standing and analysis of the mult ivariate regressions 
presented in this study allow identif ication of a 
high-risk subset of patients undergoing CABG who 
are candidates for interventions to reduce morbid-  
ity. Further  studies will use the statistical model ing 
presented here to identify the high-risk cohort  and 
to test efficacy of interventions a imed at reducing 
postoperat ive morbidity in this high-risk group. 
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Discussion 
Dr. Fred H. Edwards (Jacksonville, Fla.). Up to this 
point, virtually all reported risk models have focused on 
operative mortality as the outcome variable. Dr. Ferraris 
has pushed out the envelope a bit by modeling morbidity 
rather than mortality. This is clearly more challenging, 
and in the past there has been some question as to 
whether one could reliably predict postoperative morbid- 
ity. 
The Society of Thoracic Surgeons Database Committee 
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has been interested in this concept for some time. To 
emphasize the point that morbidity can be reliably pre- 
dicted, ! would like to describe some representative 
results from more than 40,000 patients undergoing coro- 
nary bypass urgery in 1993. The models were based on a 
Bayesian algorithm and show good agreement between 
our predicted and observed results. In our LOS model, 
there is no deviation between the two curves until you 
reach the range of 2 weeks and greater. This is also true 
for our model of prolonged postoperative ntilation and 
for our model of postoperative stroke. 
So we can do this. Logic dictates that it should be able 
to help us minimize our postoperative morbidity. But do 
we have any clinical evidence that these predictive models 
really help? Dr. Ferraris, have you seen any real reduction 
in your postoperative morbidity as a result of this study? 
I wonder whether managed care groups should have 
access to this kind of analysis. It is obvious that these 
groups will impose restrictions on patient care and the 
restrictions will be based on their own arbitrary and 
sometimes hopelessly superficial criteria. Should we en- 
courage managed care groups to use risk-adjusted analy- 
ses like the one you have presented, or should these risk 
models tay with the surgeon for purely clinical consider- 
ations? 
Dr. Ferraris. Thank you, Dr. Edwards, for your com- 
ments. We are all aware of your efforts involved in risk 
stratification and risk identification, especially related to 
the Society of Thoracic Surgeons database. 
The answer to your questions probably will be a little bit 
philosophic. First of all, these studies were formulated and 
designed as part of a process of improving patient out- 
comes, not decreasing costs. Of course, cost inevitably 
creeps in when managed care discussions come up, and we 
certainly hope that by decreasing morbidity we will also 
decrease costs. This seems likely, but, as yet, that is an 
unproved hypothesis. Organizations that pay for health 
care are interested in cost, probably more than in out- 
comes. I think for physicians to get involved in this process 
is very important. We are not at the point where we have 
to limit care based on costs, and we have to be involved in 
the risk identification and stratification process to provide 
optimal cost-effective care. 
Clinically, we are still at the point where we are 
identifying risks. We have not applied this in a prospective 
manner yet, although we certainly intend to do that. The 
sought-after goal would be to reduce risks on the basis of 
this risk stratification, identifying high-risk patients who 
are likely to benefit from some intervention. Perhaps next 
year we can talk more about clinical applications. 
Dr. Robert A. Guyton (Atlanta, Ga.). I have a question 
related to the use of composite variables. I have no 
difficulty with a composite variable when two variables are 
physiologically related, such as red cell volume and age, 
but I do have some concern with the probability of a 
mortality composite variable in which unrelated variables 
are pulled together. Do you think that the inclusion of 
probability of mortality is the reason, for example, that 
age was not a predictor of mortality but was a predictor of 
morbidity and that is the reason that you have different 
risk factors for mortality than you have for morbidity? 
Dr. Ferraris. The issue of the composite variables is a 
little bit sticky. The PROBMORT variable is actually a 
variable that is generated by a New York State database. 
It has 12 or 15 variables within it, one of which is age. Thus 
there is some overlap among the variables that were used 
in the equation. From the point of view of constructing a 
model that you apply to the statistics, you want to 
minimize these variable interactions. As long as you can 
come up with a meaningful model, then I think it is 
reasonable to do this. The reason for including the 
PROBMORT variable was that this is something that has 
been proved in a large number of patients to correlate 
with mortality. We thought hat by showing that it does 
indeed predict mortality, we have some validation of our 
statistical methods in our model. 
Dr. Bruce A. Reitz (Stanford, Calif.). Dr. Ferraris, I
wonder if you would comment on what additional infor- 
mation is gained from your database as opposed to the 
Society of Thoracic Surgeons or the New York State 
database, 
Dr. Ferraris. Our database is smaller than the other 
two. Our method would have to be applied in larger 
databases toreally validate the method. We would hope to 
show that it is possible to identify risk factors from a set of 
variables and from statistical modeling. It remains for this 
model to be tested in larger databases, uch as the Society 
of Thoracic Surgeons or the New York State database. 
Appendixes 1 and 2 are on pages 740 and 741. 
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Appendix 1. Definitions and values of variables used in multivariate analyses 
Mean or % 
Variable Definition with variable 95% CI 
Outcome variables 
Mortality In-hospital death 2.6% 1.0% 
LOS Days from operation to discharge or death 8.40 days 0.45 days 
Morbidity One or more of the following: stroke, MI, sepsis, low 8.5% 1.8% 
cardiac output requiring IABP or LVAD, renal failure, 
or pulmonary failure 
Continuous predictor variables 
Age 
Age/RBCVOL 
Preop. hematocrit value 
Preop. platelet count 
BSA 
Ejection fraction 
PROBMORT 
Discrete predictor variables 
Females 
Left main disease 
Fresh MI 
Emergency OR 
Reop. 1 
Reop. 2 
Previous stroke 
Femoral popliteal disease 
Preop. shock 
Hypertension 
Unstable angina 
LVH 
CHF 
Ventricular arrhythmias 
COPD 
Diabetes 
Hepatic failure 
Renal failure 
Renal dysfunction 
Immune deficit 
Cath crash 
PTCA crash 
Age in years 64.6 years 0.68 years 
Age in years divided by red blood cell volume estimated 0.0390 yr/ml 0.0009 yr/ml 
from nomogram 
Hematocrit measured 24 hours before operation 39.4% 0.3% 
Platelet count measured 24 hours before operation 250 5 
(number/liter) 
Body surface area estimated from nomogram of body weight, 1.93 m 2 0.02 m 2 
height, and gender 
Ejection fraction measured from preoperative catheterization 50.1% 1.0% 
Predicted probability of death estimated from the NY State 0.0250 0.003 
risk-adjusted mortality score (see Appendix 2) 
Percent of patients who were female 29.2% 2.9% 
Left main obstruction -> 90% 4.9% 1.4% 
MI within 7 days before operation 8.0% 1.7% 
Operation performed in next available OR after diagnosis made 5.8% 3.7% 
First reoperative procedure 4.8% 1.4% 
Second reoperative procedure 0.1% 0.2% 
Stroke resulting in permanent deficit 5.4% 1.5% 
Arterial obstruction of >50% in the femoral popliteal 7.9% 1.7% 
distribution documented by arteriogram or noninvasive 
diagnostic study 
Hypotension requiring pressor therapy or IABP for 5.7% 1.2% 
maintainance of blood pressure 
Diastolic hypertension requiring medication for control 68.9% 3.0% 
Rest angina requiring intravenous nitroglycerin for control 19.3% 2.5% 
Ventricular hypertrophy documented by preoperative 8.3% 1.8% 
electrocardiogram 
Preop. heart failure requiring treatment during the same 9.7% 1.9% 
admission that CABG was performed 
VT or VF requiring cardioversion or documented episode of 1.9% 0.7% 
sudden death 
Chronic lung disease requiring bronchodilator steroid therapy 22.7% 2.7% 
Glucose intolerance requiring oral or injectable medication 24.1% 2.7% 
Elevation of bilirubin > 3.0 0.20% 0.28% 
Dialysis-dependent 0.7% 0.6% 
Creatinine > 2.5 but not on dialysis 1.8% 0.8% 
AIDS or drug-induced immune deficit 1.4% 0.7% 
Emergency transfer to OR after diagnostic atheterization 1.2% 0.7% 
Emergency transfer to OR after failed PTCA 2.1% 0.9% 
CI, Confidence interval; LOS, length of stay; 3/11, myocardial infarction; IABP, intraaortic balloon pump; LVAD, left ventricular ssist device; RBCVOL, red 
blood cell volume; BSA, body surface area; PROBMORT~ probability of death; NY, New York; OR, operating room; LV/4;, left ventricular hypertrophy; CHF, 
congestive heart failure; CABG, coronary artery bypass grafting; VT;, ventricular tachycardia; VF, ventricular fibrillation; COPD, chronic obstructive 
pulmonary disease; AIDS, acquired immunodeficiency syndrome; PTCA, percutaneous transluminal coronary angioplasty. 
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Appendix 2. Risk factors and relative risk for variables that contribute to PROBMORT (from the New York 
State risk-adjusted mortality score for surgeons and hospitals) 2 
Risk factor Relative risk 
None 
Age 
Body surface area 
Myocardial infarction within 6 hours of operation 
Persistent ventricular arrhythmias 
Ejection fraction < 0.20 
Ejection fraction between 0.20 and 0.39 
Unstable hemodynamic state (intraaortic balloon pumping or pressors) 
Shock 
Chronic obstructive pulmonary disease 
Diabetes 
Dialysis-dependent renal failure 
Previous troke 
Canadian Coronary Score (class IV only) 
Femoral/popliteal vascular disease 
Previous cardiac operation 
1.000 
0.480 
11.816 
8.093 
5.777 
9.558 
4.705 
12.158 
20.032 
3.822 
4.821 
9.890 
5.928 
5.960 
6.171 
10.949 
